Clinical Trial Update: Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating letrozole in postmenopausal women with ductal carcinoma in situ of the breast has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma in Situ of the Breast

Drugs mentioned

• FEMARA (letrozole)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-03-27